Evidence map›Paper›PMID 41671340›Full record

ArticleScience translational medicine2026

Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in preclinical models of H3K27M-mutant gliomas.

Georgios Batsios, Céline Taglang, Suresh Udutha, Anne Marie Gillespie, Timothy Phoenix, Sabine Mueller, Sriram Venneti, Carl Koschmann, Pavithra Viswanath

Abstract read
In one paragraph

Article in Science translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Georgios BatsiosDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-2340-1486
Céline TaglangDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-3927-6675
Suresh UduthaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-3542-8245
Anne Marie GillespieDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-4279-3961
Timothy PhoenixDivision of Pharmaceutical Sciences, University of Cincinnati, College of Pharmacy, Cincinnati, OH 45267, USA.ORCID 0000-0003-4771-4003
Sabine MuellerDepartments of Neurology, Neurological Surgery, and Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA.
Sriram VennetiDepartment of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0001-9764-0423
Carl KoschmannDepartment of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-0825-7615
Pavithra ViswanathDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-2980-3109

Funding

Combination metabolic therapy for diffuse midline gliomaR01CA292674 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Pavithra Viswanath · 2024 to 2026
$3.3M
Targeting integrated metabolic and epigenetic pathways in childhood ependymomasR01CA261926 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Deepak Nagrath, Benita Tamrazi · 2022 to 2026
$3.0M
Unravelling metabolic dependencies in H3K27M mutant DIPGR01NS110572 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sriram Venneti · 2019 to 2026
$2.7M
Targeting metabolic dependencies in ZFTA-RELA fusion childhood ependymomasR01NS127799 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sriram Venneti · 2023 to 2026
$1.8M
Probing citrate metabolism in tumor and immune cells in diffuse midline gliomasR01CA296817 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Pavithra Viswanath · 2025 to 2026
$1.4M
Synthetic combination therapy for diffuse midline gliomasR21CA289565 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VISWANATH, PAVITHRA · 2024 to 2025
$415k
NCI NIH HHS R01 CA261926NCI NIH HHS R01 CA292674NCI NIH HHS R01 CA296817NCI NIH HHS R21 CA289565NINDS NIH HHS R01 NS110572NINDS NIH HHS R01 NS127799
6 · The paper itself

Abstract

Hyperactivation of glucose metabolism to lactate is a metabolic hallmark of cancer. However, the functional role of lactate in pediatric diffuse midline glioma (DMG) cells is unclear. Here, using stable isotope tracing and loss-of-function studies in clinically relevant patient-derived DMG models, we show that the oncogenic histone H3K27M mutation epigenetically up-regulates the rate-limiting glycolytic enzyme phosphoglycerate kinase 1 (PGK1) and drives lactate production from [U-

Indexed as

Brain NeoplasmsDeuteriumGliomaHistonesMutationNucleotidesAnimalsCell Line, TumorCell ProliferationGlucoseHumansLactic AcidMiceNM23 Nucleoside Diphosphate KinasesDeuteriumGlucoseHistonesLactic AcidNM23 Nucleoside Diphosphate KinasesNucleotides

Identifiers

PMID41671340
PMCPMC13131286

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.